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Portal systemic shunting (PSS) and portal pressure were measured in control rats and in animals
with portal hypertension induced by partial portal vein ligation (PPVL). The portal pressure in
rats with partial portal vein ligation (13.4 + 0.5 mm.Hg.) was significantly higher (p< 0.005) than
in the control group (9.6 + 0.6 mm.Hg.). Portal systemic shunting measured by consecutive
injections of radiolabelled methylene diphosphonate (MDP), a non-diffusable marker and
albumin microspheres directly into the splenic pulp was significantly increased (P< 0.005) in the
portal hypertensive animals (30.8 + 2.5%) compared to sham operated rats (2.6 + 1.5%). Simi-
larly, in portal hypertensive rats portal systemic shunting measured by intrasplenic injections of
radiolabelled cobalt microspheres (37.1 + 3.9%) was significantly greater (p< 0.005) than in
control animals. There was a good correlation and agreement (r= 00.97) between the two
methods of measuring portal systemic shunting. However because the 99Tcm-albumin micro-
spheres are biodegradable the method allows portal systemic shunting to be measured in man.
Furthermore since the computer adjusts the baseline to zero after each determination of portal
systemic shunting the methodology allows repeated measurements to be made.
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INTRODUCTION
Bleeding from gastro-oesophageal varices is a serious
and often fatal complication ofportal hypertension in
chronic liver disease. Variceal haemorrhage rarely oc-
curs unless the portal pressure exceeds 12 mm Hg1.
However, no relationship has been demonstrated be-
tween the magnitude ofportal pressure and the occur-
rence of variceal bleeding2. A possible explanation for
this observation is the relationship between portal
pressure and the blood flow through the collateral
circulation including the gastro-oesophageal varices.
Thus, although a good correlation has been demon-
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strated between azygos blood flow (an indirect mea-
surement of collateral blood flow) and portal pressure
in man, the relationship is exponential. Thus, when the
portal pressure is only mildly elevated above normal in
portal hypertensive patients, further relatively large
increases in pressure result in only modest elevations in
azygos blood flow3. Conversely when the portal pres-
sure is markedly elevated, further small increases in
pressure result in large elevations in azygos blood flow3.
Furthermore, recent studies have indicated that vaso-
active drugs have a differential action on portal pres-
sure and azygos blood flow4,5. Measurement of collat-
eral blood flow therefore gives information over and
above that available from measurements ofportal pres-
sure alone both with respect to the pathophysiology of
variceal bleeding and the effects of vasoactive drugs
used to control haemorrhage and long-term manage-
ment of portal hypertension.
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Currently measurement ofazygos blood flow is the
method of choice for measuring collateral blood flow
in man. However, the technique is relatively difficult,
expensive and confined to centres that have particular
expertise in determining azygos blood flow. Further-
more, the azygos system drains blood not only from
the collateral circulation, but also from the posterior
costal, mediastinal and bronchial veins. It generally
assumed that alterations in azygos blood flow in por-
tal hypertensive patients reflect changes in collateral
blood flow and that the proportion of blood draining
into the system from the other veins is relatively con-
stant. However, this may not be the case if cardiac
output and regional blood flow are both altered,
which is often the case in portal hypertension. There-
fore, there is clearly a need for a simple method of
measuring collateral blood flow per se. In portal
hypertensive animals collateral blood flow can be
measured directly by intrasplenic injection of non-
biodegradable radiolabelled microspheres6. This tech-
nique is obviously not applicable to patients. Further-
more, even in experimental animals the microsphere
method ofdetermining collateral blood flow has limi-
tations. Thus, the number of consecutive measure-
ments ofcollateral blood flow is limited by the need to
select microspheres labelled with isotopes of widely
varying energies to facilitate subsequent counting.
Although numerous attempts have been made to de-
termine extrahepatic PSS scintigraphically after ad-
ministration of biodegradable radiolabelled aggre-
gates (MAA) or microspheres of human serum albu-
min, there are a number ofmethodological difficulties
in the techniques hitherto described. Thus, in the ma-
jority of studies a radiolabelled reference marker ex-
tracted by the Kuppfer cells is used in conjunction
with either human albumin macroaggregates (MAA)
or microspheres. However, implicit in the calculation
of a shunt index is the assumption that the reference
marker is almost completely extracted from the blood
by the Kuppfer cells on a single passage through the
liver. This is clearly not the case in liver disease since
Kuppfer cell activity is compromised, often severely,
in patients with advanced disease. Furthermore, re-
peated estimations of PSS are not possible since the
Kuppfer cells become saturated with reference
marker. We describe here a method for measuring
collateral blood flow using consecutive injection of
99TCm methylene diphosphonate and 99Tcm-albumin
microspheres directly into the splenic pulp. Since the
computer software recalibrates the baseline after each
injection of radioisotope, the technique allows mul-
tiple measurements ofcollateral blood flow to be made.
METHODS
Radiolabelling ofmicrospheres
Reaction vials contained 2.5 mg Human Serum Albu-
min microspheres (Rotop Akademie der Wissen-
schaften, Germany) 0.1 mg SnClz2H20 and 0.6 mg
Tween 80. (pH 4.7). Approximately 3-5 105 micro-
spheres with a mean diameter of 20/ (range 10-30
were present in 2.5 mg of albumin microspheres. The
vials were reconstituted with 300 MBq of 99mTc04 in a
volume of3 ml isotonic saline. The labelling yield was in
the order of99% as ascertained by paper chromatogra-
phy using methanol: water (85:15) as the solvent.
Carbonised microspheres (NEN-Trac, Dupont),
15.5 u + 0.1 / diameter labelled with 57Cobalt (57Co),
51Chromium (51Cr)and 46Scandium (46Sc) were sus-
pended in 0.9% saline and 0.01% Tween 80. Vials con-
tained 3.04 x 105 microspheres per mg with 41.3 mg per
vial.
Experimental design
Male Wistar rats, 250-350g body weight, were ran-
domly assigned to one of two groups, each containing
twenty-two animals. One group underwent partial por-
tal vein ligation to induce portal hypertension and the
development of a substantial collateral circulation.
Briefly, (after an overnight fast) the rats were anaes-
thetised by an intramuscular injection of Immobilon
(Etorphine/Methorimeprazine). The abdomen was
opened through a midline incision and the portal vein
identified and mobilised at a point cranial to itsjunction
with the pancreaticoduodenal vein. A single 5/0 silk
ligature was passed around the portal vein and tied so as
to include a 20G blunt needle. The needle was with-
drawn and the vessel allowed to re-expand, resulting in
an approximately uniform stenosis of the portal vein
(0.9 mm.) in all animals. The abdomen was closed in a
single layer using 3/0 silk sutures and anaesthesia re-
versed by an intramuscular injection of the etorphine
antagonist Revivon (Diprenorphine).
The second group of rats underwent a sham opera-
tion in which the abdomen was opened, the portal vein
mobilised and the laparotomy closed in single layer.
Hepatic Haemodynamics were determined not less
than two weeks and not more than four weeks after
partial portal vein ligation or sham operation to allow
the development of varying degrees of collateral circu-
lation in the portal hypertensive rats.
At the time of investigation all animals were
anaesthetised by intraperitoneal injection of 6 mg/Kg
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Through a midline incision the portal vein was
cannulated via a small branch of the superior mesen-
teric vein, thus minimising any effect of the procedure
on portal venous inflow. The cannula was connected
via an isolated pressure transducer (Medex Ltd.) and
amplifier to a two channel chart recorder (Lectromed
UK Ltd.). The abdominal incision was then closed to
minimise heat and evaporative loss. The spleen was
exposed through a separate, small, left lateral abdomi-
nal incision. The rats were placed under a 50mm 50
mm straight bore sodium iodide scintillation detector
positioned over the clavicular area to include the upper
pole of the lungs and shielded from the liver by a lead
shield. The detector was connected through a single
channel analyser to a gamma counter and the count
rate transferred continuously to a microcomputer
(Spherex monitoring system, Pharmacia, Sweden).
The increase in the count rate in the lung field of
interest was calculated as the difference between the
plateau level after each injection of the radionuclide
and the baseline level. The baseline was determined
from the mean of the count rate during the thirty
seconds immediately before the start of each injection.
The plateau level was calculated as the mean count rate
during sixty seconds, (the average counts per second
for six consecutive ten second periods during the stable
phase in each measurement) within a period of three
minutes from each injection. The count rate was cor-
rected for the dose of radionuclide in each injection to
obtain comparable values of the count rate per unit of
radioactivity injected. The decay of 99mTC (half-life 6
hours) and the ’deadtime’of the detector were cor-
rected for by the computer software to obtain a linear
response up to a miximum count rate of 65,000 c.p.s.
A reference dose of 15 gl 99mTc-methylene dipho-
sphonate (MDP, 100 MBq/ml) was injected directly
into the splenic pulp using a high pressure liquid chro-
matography (HPLC) syringe. MDP is a low molecular
weight non-diffusable marker which is not retained
within the liver and consequently all the radioactivity
injected passes directly to the lung field of interest.
Therefore the increase in count rate after the injection
of the MDP was calculated as the difference between
the plateau level obtained after its injection and the
baseline level and was regarded as the 100% passing
fraction (Figure 1). The injection ofMDPwas followed
three minutes later by an intrasplenic injection of the
same volume of 99mTc labelled human serum albumin
microspheres. In portal hypertensive rats the propor-
tion of albumin microspheres passing to the lungs is
proportional to the degree of extrahepatic shunting
and was calculated as a percentage ofthe 100% passing
fraction (Figure 1). In order to establish that the ad-
ministration of the albumin microspheres had not
caused any adverse haemodynamic changes in the
splanchnic circulation, a second MDP injection was
administered three minutes after the albumin
microspheres. Ifthe two MDP curves were within 10%
of each other, it was assumed that no haemodynamic
alterations had resulted from the injection of the albu-
min microspheres. If the two MDP curves were not
within these limits the animal was excluded from the
study.
After completion of the albumin microsphere
method determinations of portal systemic shunting
were repeated using 57C0 microspheres6. In brief, 40/A
0f57C0 microspheres were administered by intrasplenic
injection, the animals left for twenty minutes, killed,
the liver and lungs excised, weighed and placed in
gamma counting tubes. The radioactivity in the liver
and lungs was counted in a Canberra Packard Cobra
gamma counter seven days later, when all the99mTc had
decayed. PSS was calculated using the formula:-
%PSS net lung activity 100
net liver +lung activity
Repeated measurements ofPSS
PSS was determined in 10 portal hypertensive rats by
consecutive intrasplenic injections ofMDP and 99mTc-
albumin microspheres repetitively at 10 min. intervals
over a period of 50 min. (6 determinations in each
animal).
Statistical analysis
Paired Student’s t-tests were used to compare the de-
gree ofportal systemic shunting determined by the two
methods in the same animals. An analysis of variance
was used for the comparison of portal pressure and
portal systemic shunting between partial portal vein
ligated animals and corresponding sham operated ani-
mals. The correlation between the two methods of
measuring portal systemic shunting was determined
using Pearson’s correlation coefficient. Agreement be-
tween the methods was calculated using the method
described by Bland and Altman9. Data are presented as
mean + standard error of the mean.
RESULTS
Following the injection of 99mTc-labelled albumin
microspheres into the splenic pulp of sham operated226 J. YATES et al.
Portal
systemic
shunting
(%)
100
80
60
40
2
0
MDP
Albumin microspheres
PORTAL
HYPERTENSIVE RAT
Albumin microspheres NORMAL RAT
TIME :rain
Figure 1 Diagrammatic representation of the computer printout following intrasplenic injection of 99Tcm MDP and 99Tcm albumin
microspheres in normal and portal hypertensive rats. In normal (sham operated) animals almost all ofthe albumin microspheres are trapped
within the liver whereas in portal hypertensive rats a variable fraction passes to the lungs via the collateral circulation.
rats, almost all the radioactivity was trapped within the
hepatic capillary bed and little was detected in the lung
field of interest. Thus, in normal rats, extrahepatic
shunting (2.6 +0.7%) was minimal. Similarly, the de-
gree of portal systemic shunting calculated from the
lung:liver ratio of radioactivity following injection of
57Co microspheres was also very low (2.4 + 0.6%).
There was a good correlation (r=0.92) between the
two methods to determine portal systemic shunting in
control rats (Figure 2). Partial portal vein ligation
resulted in a significant elevation (p < 0.005) in portal
pressure 13.4 + 0.5 mm Hg) compared to that (9.6 +
0.6mm Hg) in the sham operated group. The degree of
PSS measured by both albumin and cobalt micro-
spheres was variable in the portal hypertensive rats and
was dependent on the length of time between partial
portal vein ligation and the determination of extrahe-
patic shunting. In general, PSS was greater the longer
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99 Figure 2 Correlation of portal systemic shunting determined by the Tc -albumin and 57Co-microsphere methods in sham operated rats
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Figure 3 Correlation between the two microsphere methods ofdetermining portal systemic shunting in rats with partial portal vein ligation,
(y 8.6 + 0.60x; r 0.93).
the animals were left after ligation of the portal vein.
Nevertheless, portal systemic shunting measured by
albumin microspheres (30.8+2.5%) and cobalt
microspheres (37.1 + 3.9%) was significantly increased
(p < 0.001) compared to corresponding controls.
There was a good correlation (r=0.93) between the
albumin and cobalt microsphere methods of measur-
ing portal systemic shunting in rats subjected to partial
portal vein ligation (Figure 3). Furthermore combin-
ing the results for both control rats and those with
PPVL (Figure 4) there was good correlation between
the two methods ofmeasuring PSS (r =0.97). The grao
dient from the regression equation for portal systemic
shunting in control rats was 1.04 (Figure 2) and that in
portal hypertensive animals was 0.60 (Figure 3). Com-
bining the results from both groups of rats produced a
regression equation with a gradient intermediate be-
tween these two values (Figure 4). In order to further
investigate agreement between the two methods, the
combined data of all rats were replotted (Figure 5) by
the method described by Bland and Altman8. Thus
when PSS was low all the data points were clustered
near the line of perfect agreement (zero difference).
However, as-the degree of PSS increased in the PPVL
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Figure4 Correlation between the two microsphere methods ofdetermining portal systemic combining both groups ofrats, (y 2.10+ 0.74x;
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Figure 5 Relationship of the discrepancy between portal systemic shunting measured by albumin on cobalt microspheres in all rats to the
mean PSS by the two techniques.
rats, the data points showed a slight progressive nega-
tive bias away from the line of perfect agreement.
However, the majority (40/44) of the data points fell
within the limits of agreement (mean difference
+ 2SD). Therefore there was a good agreement bet-
ween albumin and cobalt microsphere methods of
measuring PSS.
In the 10 rats who underwent repeated determi-
nations of PSS, the baseline levels were variable rang-
ing from 17-94% with a median value of 40.5%. The
reproducibility of 5 consecutive determinations ofPSS
in each ofthe animals was good with amean coefficient
of variation of 1.2%.
DISCUSSION
It is generally accepted that there is little extrahepatic
portal systemic collateral circulation in the normal rat.
Therefore, the mean portal systemic shunting mea-
surement of approximately 2.5% detected by both
microsphere methods probably reflects the degree of
intrahepatic portal systemic shunting. Subsequent eva-
luation of the degree of portal systemic shunting after
partial portal vein ligation will depend on the sum of
both intra-and extrahepatic shunting, although the
former is negligible compared to the latter.
No significant differences were found between the
two methods ofdetermining the portal systemic shunt-
ing in sham operated rats. However, the Tc-albumin
microsphere method consistently gave lower values for
portal systemic shunting than the 57C0 microsphere
method in portal hypertensive rats. This discrepancy
between the two methods of determining PSS may
possibly be related to differences in the range of diam-
eters between the 57C0 and 99m Tc microspheres used in
the study. Conceivably a greater proportion of the
larger albumin microspheres may be entrapped in the
splenic pulp after administration. However, this expla-
nation seems unlikely since our preliminary studies
indicated that less than2% ofthe injected dose ofeither
57Co or 99mTC was retained in the spleen after injection.
Furthermore, there was no significant difference be-
tween intrasplenic or mesenteric vein administration of
either STCo and 99mTc microspheres. A more attr,ctive
possibility is that in the rat, a proportion of the blood
vessels comprising the extrahepatic collateral circula-
tion have a diameter less than 17tm in which a propor-
tion of the larger 99mTC microspheres become entra-
pped. Furthermore, if the proportion of these small
ve,ssels increases as the extrahepatic collateral circula-
tion becomes more extensive, this suggestion would
also explain the greater discrepancy between the two
methods With increasing degrees ofPSS. Although this
hypothesis could not be confirmed in the present study
there was an excellent correlation between the cobalt
and albumin microsphere methods. However, the rela-
tionship between two variables derived by linear re-
gression assumes that there is no error in one of the
variables. This is obviously not the case in the present
study and an error exists in both methods ofdetermin-A NOVEL METHOD OF DETERMINING PORTAL SYSTEMIC SHUNTING 229
ing PSS. A mathematical relationship between PSS
determined by 57C0 and 99mTc-albumin microsphere
was therefore derived using a modification of the least
square technique which minimises the sum of the
squares at right angles to the curve rather than in the Y-
axis only. Using this mathematical approach an equa-
tion can be derived to relate PSS determined by 57C0
or 99nTc-albumin microspheres:
PSS shunting (57C0)% 0.75% xPSS shunting (99mTc)%
+ 1.84%
come by use of fine needles and by embolising the
needle track with gelfoam at the end of the procedure.
Using this technique it is hoped 1) to gain further
information on the role of portal pressure and collat-
eral blood flow in the pathophysiology of variceal
haemorrhage, 2) compare the relative efficacies of va-
soactive drugs on portal pressure and collateral blood
flow simultaneously in portal hypertensive patients
and 3) determine the nature and extent of the extrahe-
patic shunts.
Bland and Altman and Murray and Miller1 have
recently pointed out that a good correlation between
the results of two methods of measuring a single pa-
rameter, in this case PSS, is not necessarily an indicator
of agreement. This is borne out by the regression equa-
tions for the correlation plots ofthe data determined in
this investigation. Testing for agreement ofthe method
ofBland and Altman indicated that there was reason-
able agreement between the albumin and cobalt
microsphere methods ofdetecting PSS. However, with
increasing degrees of extrahepatic shunting the agree-
ment between the two methods is less good. Con-
sequently if the 99mTc albumin microsphere method
detects a 0.6% rise in shunting, the 57Co-microsphere
method would detect a 1% rise. In conclusion, there-
fore, the quantification of portal systemic shunting by
intrasplenic injection of 99Tc-albumin microspheres
is comparable with the 57Co-microsphere technique.
However, the 99Tc-labelled albumin microsphere
method allows for repeated measurement of portal
systemic shunting in experimental animals. Further-
more since the albumin microspheres are biodegrad-
able this method could also be applied to man. Deter-
mination of collateral blood flow in portal
hypertensive patients by intrasplenic injection of ra-
diolabelled MDP and albumin microspheres could be
used to measure collateral blood flow and portal pres-
sure simultaneously. This would be particularly advan-
tageous in patients with non-alcohol related cirrhosis
with a pre-sinusoidal component to their portal hyper-
tension since measurements of corrected wedged he-
patic venous pressure (WHVP) do not accurately re-
flect the portal pressure. There is a risk ofhaemorrhage
associated with splenic puncture but this can be over-
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